Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

SD Lawn, P Mwaba, M Bates, A Piatek… - The Lancet infectious …, 2013 - thelancet.com
Rapid progress has been made in the development of new diagnostic assays for tuberculosis
in recent years. New technologies have been developed and assessed, and are now …

[HTML][HTML] Rapid spread of Zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games

…, ME Wilson, S Touch, B McCloskey, P Mwaba… - International Journal of …, 2016 - Elsevier
Mass gatherings at major international sporting events put millions of international travelers
and local host-country residents at risk of acquiring infectious diseases, including locally …

[HTML][HTML] Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts

…, SD Lawn, GB Migliori, P Mwaba, P Glaziou… - The Lancet infectious …, 2013 - thelancet.com
Recent data for the global burden of disease reflect major demographic and lifestyle
changes, leading to a rise in non-communicable diseases. Most countries with high levels of …

[HTML][HTML] Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts

…, F Ntoumi, E Aklillu, R Fatima, P Mwaba… - International journal of …, 2021 - Elsevier
The October 2020 Global TB report reviews TB control strategies and United Nations (UN)
targets set in the political declaration at the September 2018 UN General Assembly high-level …

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled …

…, M Hoelscher, D Dowdy, A Pym, P Mwaba, P Mason… - The Lancet, 2014 - thelancet.com
… We used Fisher's exact test with mid-p correction for comparisons between proportions,
and the Mann-Whitney test to compare differences in morbidity. We assessed inter-rater …

Emergence of new SARS-CoV-2 Variant of Concern Omicron (B. 1.1. 529)-highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of …

…, L Mucheleng'anga, J Tembo, P Mwaba… - International Journal of …, 2022 - ijidonline.com
Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5
million deaths, the world continues to be on high COVID-19 alert. The World Health …

Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study

…, A Nunn, K Lishimpi, D Maswahu, F Kasolo, P Mwaba… - The Lancet, 2002 - thelancet.com
… C Chintu, K Lishimpi, G Bhat, and P Mwaba provided clinical care and counselling, and
recruited patients. A Nunn provided statistical expertise and data management. F Kasolo and H …

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

…, M Hosp, P Godfrey-Faussett, M Quigley, P Mwaba… - Aids, 1998 - journals.lww.com
Background: A randomized double-blind placebo-controlled trial was conducted to estimate
the efficacy of preventive therapy for tuberculosis (TB) in HIV-infected adults in Lusaka, …

[HTML][HTML] Drug-resistant tuberculosis: time for visionary political leadership

…, BJ Marais, TD McHugh, P Mwaba… - The Lancet infectious …, 2013 - thelancet.com
Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly
cost-effective directly observed treatment short-course programme to control the epidemic…

[HTML][HTML] Antifungal combinations for treatment of cryptococcal meningitis in Africa

…, V Sini, YN Mapoure, P Mwaba… - … England Journal of …, 2018 - Mass Medical Soc
Background Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency
virus (HIV)–related deaths per year. We tested two treatment strategies that could be …